Comprehensive metabolomics expands precision medicine for triple-negative breast cancerYi Xiao, Yi‐Zhou Jiang|Cell Research|2022Cited by 315
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligenceYing Xu, Yi‐Zhou Jiang, Guan-Hua Su et al.|Signal Transduction and Targeted Therapy|2021Cited by 171
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targetsGuan-Hua Su, Yi‐Zhou Jiang, Yi Xiao et al.|Science Advances|2023Cited by 114
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancerLin Jiang, Chao You, Yi Xiao et al.|Cell Reports Medicine|2022Cited by 92
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancerXi Jin, Yi‐Zhou Jiang|Molecular Cancer|2020Cited by 92